Designing the Path, Driving the Impact

• Exploring a strategic, case-based perspective on how MIDD connects evidence, learning, and decisions across development; from translational evidence and first-inhuman strategy through adaptive dose and regimen optimization to proof-of-concept planning
• Explaining how using complex oncology biologics to illustrate how quantitative insights can shape the development path

Speakers: